This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Stichting Radboud Universitair Medisch Centrum. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Roel Hammink: Innovator in Immunomodulatory Nanofilaments
Introduction
Roel Hammink is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of immunology through his innovative work on nanofilaments that modulate immune responses. His research focuses on enhancing the interaction between immune factors and immune cells, particularly T cells.
Latest Patents
Hammink holds a patent for "Immunomodulatory Nanofilaments." This invention presents immune factors, especially cytokines, to immune cells, thereby modulating the immune response of these cells. The methods of using such nanofilaments are also detailed in his patent, showcasing their potential applications in medical treatments.
Career Highlights
Roel Hammink is affiliated with the Radboud University Medical Center, where he conducts his research. His work is pivotal in advancing the understanding of immune modulation and its implications for therapeutic interventions.
Collaborations
Hammink collaborates with esteemed colleagues such as Carl Gustav Figdor and Loek Eggermont. Their combined expertise contributes to the innovative research being conducted at the Radboud University Medical Center.
Conclusion
Roel Hammink's contributions to the field of immunology through his patent on immunomodulatory nanofilaments highlight his role as an influential inventor. His work has the potential to impact medical treatments significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile